The safety profile was consistent with GLP-1 receptor agonists, primarily featuring transient, mild-to-moderate gastrointestinal adverse events (e.g., nausea, 55%), with low discontinuation rates (6-8.4%)
Linezolid-induced lactic acidosis may result from the drugs interference with mitochondrial ribosomes, inhibiting protein synthesis, reducing respiratory chain enzymes, and accelerating glycolysis that leads to lactate overproduction independent of tissue hypoxia (Santini et al., 2017)
always discuss any changes with your treating doctor
Starting Dose 100 mcg per injection Conservative entry dose
While that study did not report runaway tumor growth either, the lack of a spectacular reduction in tumor size, suggests BPC-157 offers no anti-cancer benefit and it leaves open the worry that it could even accelerate malignancy under the right conditions